Nutex Health (NUTX) Other financing activities (2012 - 2022)

Nutex Health has disclosed Other financing activities across 8 years of filings, most recently posting $81249.0 for Q3 2022.

• Other financing activities for Q3 2022 came in at $81249.0, down 53.37% year-over-year; the trailing twelve-month figure through Sep 2022 was $210268.0 (down 45.61% YoY), and the FY2021 annual result was $47875.0, down 77.59% from the prior year.
• Other financing activities came in at $81249.0 for Q3 2022 at Nutex Health, up from $54166.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.9 million in Q1 2021 to a low of -$3.9 million in Q2 2021.
• The 5-year median for Other financing activities is $79557.0 (2019), against an average of $156154.8.
• Peak annual rise in Other financing activities reached 10460.42% in 2021, while the deepest fall reached 1174.59% in 2021.
• Nutex Health's Other financing activities stood at $367300.0 in 2018, then plunged by 78.8% to $77865.0 in 2019, then surged by 172.71% to $212348.0 in 2020, then tumbled by 77.65% to $47465.0 in 2021, then jumped by 71.18% to $81249.0 in 2022.
• The last three Other financing activities figures came in at $81249.0 (Q3 2022), $54166.0 (Q2 2022), and $27388.0 (Q1 2022), per Business Quant data.